Inman Jager Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Inman Jager Wealth Management's PFE Position: Q1 2026 in Review
Inman Jager Wealth Management increased its Pfizer (PFE) stake by 7.2% in Q1 2026, buying an estimated $87.4K and bringing the position to 48,965 shares worth $1.37M. The position accounts for 0.8% of the portfolio, ranked #43.
Inman Jager Wealth Management first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Inman Jager Wealth Management held 48,965 shares of Pfizer worth $1.37M as of Q1 2026.
- Inman Jager Wealth Management bought 3,283 Pfizer shares in Q1 2026, an estimated $87.4K.
- Pfizer made up 0.8% of Inman Jager Wealth Management's portfolio in Q1 2026, its #43 holding.
- Inman Jager Wealth Management first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Inman Jager Wealth Management's 13F filing for Q1 2026, filed 23 Apr 2026.